Literature DB >> 28670758

Congenital Long QT syndrome and torsade de pointes.

Nabil El-Sherif1,2, Gioia Turitto3, Mohamed Boutjdir1,2,4.   

Abstract

Since its initial description by Jervell and Lange-Nielsen in 1957, the congenital long QT syndrome (LQTS) has been the most investigated cardiac ion channelopathy. A prolonged QT interval in the surface electrocardiogram is the sine qua non of the LQTS and is a surrogate measure of the ventricular action potential duration (APD). Congenital as well as acquired alterations in certain cardiac ion channels can affect their currents in such a way as to increase the APD and hence the QT interval. The inhomogeneous lengthening of the APD across the ventricular wall results in dispersion of APD. This together with the tendency of prolonged APD to be associated with oscillations at the plateau level, termed early afterdepolarizations (EADs), provides the substrate of ventricular tachyarrhythmia associated with LQTS, usually referred to as torsade de pointes (TdP) VT. This review will discuss the genetic, molecular, and phenotype characteristics of congenital LQTS as well as current management strategies and future directions in the field.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cellular electrophysiology; electrophsiology long QT syndrome; genetics; ion channels and membrane transporters; ventricular tachycardia

Mesh:

Substances:

Year:  2017        PMID: 28670758      PMCID: PMC6931590          DOI: 10.1111/anec.12481

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  80 in total

1.  Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.

Authors:  Marta Tomás; Carlo Napolitano; Luciana De Giuli; Raffaella Bloise; Isaac Subirana; Alberto Malovini; Riccardo Bellazzi; Dan E Arking; Eduardo Marban; Aravinda Chakravarti; Peter M Spooner; Silvia G Priori
Journal:  J Am Coll Cardiol       Date:  2010-06-15       Impact factor: 24.094

2.  Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome.

Authors:  J Junker; W Haverkamp; E Schulze-Bahr; L Eckardt; W Paulus; R Kiefer
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

3.  Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Arthur J Moss; John R Windle; W Jackson Hall; Wojciech Zareba; Jennifer L Robinson; Scott McNitt; Patricia Severski; Spencer Rosero; James P Daubert; Ming Qi; Michael Cieciorka; Allan S Manalan
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

4.  Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome.

Authors:  W Shimizu; T Kurita; K Matsuo; K Suyama; N Aihara; S Kamakura; J A Towbin; K Shimomura
Journal:  Circulation       Date:  1998-04-28       Impact factor: 29.690

5.  Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?

Authors:  E D Andersen; P A Krasilnikoff; H Overvad
Journal:  Acta Paediatr Scand       Date:  1971-09

6.  The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome. Tridimensional mapping of activation and recovery patterns.

Authors:  N el-Sherif; E B Caref; H Yin; M Restivo
Journal:  Circ Res       Date:  1996-09       Impact factor: 17.367

Review 7.  Role of pharmacotherapy in cardiac ion channelopathies.

Authors:  Nabil El-Sherif; Mohamed Boutjdir
Journal:  Pharmacol Ther       Date:  2015-09-12       Impact factor: 12.310

8.  Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.

Authors:  Arthur J Moss; Wojciech Zareba; Karl Q Schwarz; Spencer Rosero; Scott McNitt; Jennifer L Robinson
Journal:  J Cardiovasc Electrophysiol       Date:  2008-07-25

9.  Mutation of an A-kinase-anchoring protein causes long-QT syndrome.

Authors:  Lei Chen; Michelle L Marquardt; David J Tester; Kevin J Sampson; Michael J Ackerman; Robert S Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

Review 10.  Congenital Long QT syndrome and torsade de pointes.

Authors:  Nabil El-Sherif; Gioia Turitto; Mohamed Boutjdir
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-07-02       Impact factor: 1.468

View more
  13 in total

1.  Atrial Fibrillation in Long QT Syndrome by Genotype.

Authors:  Pyotr G Platonov; Scott McNitt; Bronislava Polonsky; Spencer Z Rosero; Wojciech Zareba
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-10-15

2.  Prediction of arrhythmia susceptibility through mathematical modeling and machine learning.

Authors:  Meera Varshneya; Xueyan Mei; Eric A Sobie
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

Review 3.  Congenital Long QT syndrome and torsade de pointes.

Authors:  Nabil El-Sherif; Gioia Turitto; Mohamed Boutjdir
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-07-02       Impact factor: 1.468

Review 4.  Racial Disparities in Ion Channelopathies and Inherited Cardiovascular Diseases Associated With Sudden Cardiac Death.

Authors:  Mohamed Chahine; John M Fontaine; Mohamed Boutjdir
Journal:  J Am Heart Assoc       Date:  2022-03-04       Impact factor: 6.106

5.  Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men.

Authors:  Pietro Enea Lazzerini; Silvia Cantara; Iacopo Bertolozzi; Riccardo Accioli; Viola Salvini; Alessandra Cartocci; Antonio D'Errico; Fausta Sestini; Stefania Bisogno; Gabriele Cevenini; Matteo Capecchi; Franco Laghi-Pasini; Maria Grazia Castagna; Maurizio Acampa; Mohamed Boutjdir; Pier Leopoldo Capecchi
Journal:  J Am Heart Assoc       Date:  2021-12-22       Impact factor: 6.106

Review 6.  Sudden Unexplained Nocturnal Death Syndrome: The Hundred Years' Enigma.

Authors:  Jingjing Zheng; Da Zheng; Terry Su; Jianding Cheng
Journal:  J Am Heart Assoc       Date:  2018-03-03       Impact factor: 5.501

7.  Tetrodotoxin-sensitive Navs contribute to early and delayed afterdepolarizations in long QT arrhythmia models.

Authors:  Megan Koleske; Ingrid Bonilla; Justin Thomas; Naveed Zaman; Stephen Baine; Bjorn C Knollmann; Rengasayee Veeraraghavan; Sándor Györke; Przemysław B Radwański
Journal:  J Gen Physiol       Date:  2018-05-23       Impact factor: 4.086

8.  Adaptation of ventricular repolarization duration and dispersion during changes in heart rate induced by atrial stimulation.

Authors:  Karl-Jonas Axelsson; Adam Brännlund; Lennart Gransberg; Gunilla Lundahl; Farzad Vahedi; Lennart Bergfeldt
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-11-10       Impact factor: 1.468

Review 9.  Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Nabil El-Sherif; Franco Laghi-Pasini; Mohamed Boutjdir
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

Review 10.  Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients.

Authors:  Makoto Ono; Don E Burgess; Elizabeth A Schroder; Claude S Elayi; Corey L Anderson; Craig T January; Bin Sun; Kalyan Immadisetty; Peter M Kekenes-Huskey; Brian P Delisle
Journal:  Biomolecules       Date:  2020-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.